ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,386, issued on March 31, was assigned to GigaGen Inc. (San Carlos, Calif.).

"Recombinant polyclonal proteins and methods of use thereof" was invented by David Scott Johnson (San Francisco), Adam Shultz Adler (Belmont, Calif.), Rena Aviva Mizrahi (Pacifica, Calif.), Yoong Wearn Lim (South San Francisco, Calif.), Michael Asensio (South San Francisco, Calif.), Sheila Keating (South San Francisco, Calif.), Renee Leong (Daly City, Calif.) and Jackson Leong (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compositions comprising recombinant polyclonal proteins (RPPs) derived from mammalian plasma cells and plasmablasts. A...